Product Information
CICLOPIROX 0.77% CREAM is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2077 per GM under NDC 68462029717. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 10, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.7 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462029717
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CICLOPIROX OLAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA090273FDA Approved
11/10/2009
TE Code
AB
On Market Since
11/13/2009
Pharmacological Classes
Price Statistics
The NADAC for CICLOPIROX 0.77% CREAM has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 49.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2077 per GM |
|---|---|
| All-time high | $0.6651 (Mar 12, 2014) |
| All-time low | $0.1839 (Apr 17, 2024) |
| 52-week high | $0.2829 |
| 52-week low | $0.2059 |
| Median price | $0.2999 |
| Average price | $0.3305 |
| Largest weekly change | +75.2% (Aug 22, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ciclopirox Olamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CICLOPIROX 0.77% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for CICLOPIROX 0.77% CREAM, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2077 per GM (NDC 68462029717), effective Sep 30, 2026.
How has the price of CICLOPIROX 0.77% CREAM changed over time?
Over the history we have for it, the NADAC for CICLOPIROX 0.77% CREAM has declined 49.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CICLOPIROX 0.77% CREAM?
Since Nov 28, 2013, the NADAC for CICLOPIROX 0.77% CREAM has ranged from a low of $0.1839 (Apr 17, 2024) to a high of $0.6651 (Mar 12, 2014), with a median of $0.2999 per GM.
Are there cheaper alternatives to CICLOPIROX 0.77% CREAM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CICLOPIROX 0.77% CREAM, is $0.1025 per GM — about 51% below CICLOPIROX 0.77% CREAM.
Who manufactures CICLOPIROX 0.77% CREAM?
CICLOPIROX 0.77% CREAM (NDC 68462029717) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.